UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer

Annals of oncology, 2020-03, Vol.31 (3), p.395-403

2020

Volltextzugriff (PDF)

Key role for liquid biopsy in the elimination of breast cancer surgery following neoadjuvant therapy

Annals of oncology, 2021-03, Vol.32 (3), p.423-423

2021

Volltextzugriff (PDF)

PH motifs in PAR1&2 endow breast cancer growth

Nature communications, 2015-11, Vol.6 (1), p.8853-8853, Article 8853

2015

Volltextzugriff (PDF)

PH-domains as central modulators driving tumor growth

Cell cycle (Georgetown, Tex.), 2016-03, Vol.15 (5), p.615-616

2016

Volltextzugriff (PDF)

Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

Annals of oncology, 2018-10, Vol.29, p.viii70-viii70

2018

Volltextzugriff (PDF)

Protease-activated receptors (PARs) in cancer: Novel biased signaling and targets for therapy

Methods in cell biology, 2016, Vol.132, p.341-358

2016

Volltextzugriff (PDF)

35P Unemployment risk among lung cancer survivors: A population based study

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S70-S70

2016

Volltextzugriff (PDF)

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation

Journal of clinical oncology, 1997-03, Vol.15 (3), p.987-993

1997

Volltextzugriff (PDF)

1963 First prospective outcome data in 930 patients with more than 5 year median follow up in whom treatment decisions in clinical practice have been made incorporating the 21-Gene Recurrence Score

European journal of cancer (1990), 2015-09, Vol.51, p.S321-S321

2015

Volltextzugriff (PDF)

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1777-1785

1995

Volltextzugriff (PDF)

Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings

Critical reviews in oncology/hematology, 2003-04, Vol.46 (1), p.5-16

2003

Volltextzugriff (PDF)

Recurrence score results in elderly patients with estrogen receptor positive early breast cancer

Journal of geriatric oncology, 2013-10, Vol.4, p.S33-S33

2013

Volltextzugriff (PDF)

Re: Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Metastatic Hormone-Refractory Prostate Cancer

JNCI : Journal of the National Cancer Institute, 2005-02, Vol.97 (3), p.235-236

2005

Volltextzugriff (PDF)

Prognostic Significance of Cytokeratin Markers in Breast Cancer –a Meta Analysis

Biomedicine & pharmacotherapy, 2008, Vol.62 (8), p.518-518

2008

Volltextzugriff (PDF)

Changes in psychological distress of women in long-term remission from breast cancer in two different geographical settings: a randomized study

Supportive care in cancer, 2004-01, Vol.12 (1), p.10-18

2004

Volltextzugriff (PDF)

218PAutoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

P249 - Ten-year clinical outcomes in >1000 node-negative (N0) Estrogen Receptor (ER)+ breast cancer (BC) patients (Pts) where treatment decisions incorporated the Recurrence Score Results: a registry analysis using TAILORx categorization

Breast (Edinburgh), 2019-03, Vol.44, p.S102-S102

2019

Volltextzugriff (PDF)

Ten-year clinical outcomes in >1000 node-negative (N0) Estrogen Receptor (ER)+ breast cancer (BC) patients (Pts) where treatment decisions incorporated the Recurrence Score Results: a registry analysis using TAILORx categorization

Breast (Edinburgh), 2019-03, Vol.44, p.S102

2019

Volltextzugriff (PDF)

Thrombin receptor overexpression in malignant and physiological invasion processes

Nature medicine, 1998-08, Vol.4 (8), p.909-914

1998

Volltextzugriff (PDF)

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

Cancer, 2000-09, Vol.89 (5), p.1037-1047

2000

Volltextzugriff (PDF)

Do different cultural settings affect the psychological distress of women with breast cancer? A randomized study

European journal of cancer care, 2003-09, Vol.12 (3), p.263-273

2003

Volltextzugriff (PDF)

Chapter 16 - Protease-activated receptors (PARs) in cancer: Novel biased signaling and targets for therapy

Methods in cell biology, 2016-01, Vol.132, p.341-358

2016

Volltextzugriff (PDF)

Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer

American journal of obstetrics and gynecology, 1996, Vol.174 (1), p.141-144

1996

Volltextzugriff (PDF)

Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients

Annals of oncology, 2016-10, Vol.27, p.vi26-vi26

2016

Volltextzugriff (PDF)

Progressive Muscle Relaxation and Guided Imagery in cancer patients

General hospital psychiatry, 1994-09, Vol.16 (5), p.340-347

1994

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(78)
Hebräisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(46)
Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Female
(37)
Middle Aged
(30)
Biological And Medical Sciences
(26)
Medical Sciences
(25)
Oncology
(24)
Adult
(21)
Aged
(19)
Breast Cancer
(14)
Chemotherapy
(14)
Male
(14)
Breast Neoplasms - Pathology
(12)
Pharmacology. Drug Treatments
(12)
Antineoplastic Agents
(10)
Tumors
(9)
Breast Neoplasms - Drug Therapy
(8)
Doxorubicin - Administration & Dosage
(7)
Drug Administration Schedule
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer

Key role for liquid biopsy in the elimination of breast cancer surgery following neoadjuvant therapy

PH motifs in PAR1&2 endow breast cancer growth

PH-domains as central modulators driving tumor growth

Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

Protease-activated receptors (PARs) in cancer: Novel biased signaling and targets for therapy

35P Unemployment risk among lung cancer survivors: A population based study

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation

1963 First prospective outcome data in 930 patients with more than 5 year median follow up in whom treatment decisions in clinical practice have been made incorporating the 21-Gene Recurrence Score

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies

Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings

Recurrence score results in elderly patients with estrogen receptor positive early breast cancer

Re: Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Metastatic Hormone-Refractory Prostate Cancer

Prognostic Significance of Cytokeratin Markers in Breast Cancer –a Meta Analysis

Changes in psychological distress of women in long-term remission from breast cancer in two different geographical settings: a randomized study

218PAutoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

P249 - Ten-year clinical outcomes in >1000 node-negative (N0) Estrogen Receptor (ER)+ breast cancer (BC) patients (Pts) where treatment decisions incorporated the Recurrence Score Results: a registry analysis using TAILORx categorization

Ten-year clinical outcomes in >1000 node-negative (N0) Estrogen Receptor (ER)+ breast cancer (BC) patients (Pts) where treatment decisions incorporated the Recurrence Score Results: a registry analysis using TAILORx categorization

Thrombin receptor overexpression in malignant and physiological invasion processes

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

Do different cultural settings affect the psychological distress of women with breast cancer? A randomized study

Chapter 16 - Protease-activated receptors (PARs) in cancer: Novel biased signaling and targets for therapy

Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer

Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients

Progressive Muscle Relaxation and Guided Imagery in cancer patients

Suchergebnisse filtern